• Home  
  • Solbasium Introduces Quantum Roller with Dual Light Therapy
- News

Solbasium Introduces Quantum Roller with Dual Light Therapy

Solbasium, an American company focused on science-backed red light therapy and recovery technology, has announced plans to launch the Solbasium Quantum Roller, a patented recovery device that combines myofascial rolling, tissue compression and dual red and near-infrared light therapy in a single portable system. Developed for athletes, clinicians, and wellness enthusiasts, the Quantum Roller is […]

Solbasium, an American company focused on science-backed red light therapy and recovery technology, has announced plans to launch the Solbasium Quantum Roller, a patented recovery device that combines myofascial rolling, tissue compression and dual red and near-infrared light therapy in a single portable system.

Developed for athletes, clinicians, and wellness enthusiasts, the Quantum Roller is intended to support both mechanical and cellular recovery by targeting muscles, joints, connective tissue and facial areas while delivering therapeutic light during use.

How does the Quantum Roller differ from traditional foam or vibrating rollers? According to the company, it integrates 90 high-powered LEDs with active compression, allowing bodyweight to bring the light source closer to target tissue for more effective light delivery.

Solbasium also claims the Quantum Roller is the first recovery roller to feature a removable battery system, enabling users to replace batteries within seconds to eliminate charging downtime and enable continuous use in training centres, clinics and other high-performance settings.  

Bradley Carden, Founder and CEO of Solbasium, said, “Recovery technology has remained largely unchanged for decades. We set out to create an entirely new category by combining foam rolling, tissue compression, red light therapy, and a removable battery system into a single device.”

The company said the Quantum Roller is protected by granted design patents, with additional intellectual property filings underway.

The product is scheduled to launch on Kickstarter next month, with early access pricing starting at USD 249. Early Bird pricing will be set at USD 299, followed by standard Kickstarter pricing of USD 349. The product is expected to retail at an MSRP of USD 399.99.

Pilot production is planned for October 2026, followed by mass production in November. Initial customer deliveries are expected between December 2026 and January 2027.

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Contact: +91 8447496924

HealthXploreIndia @2026. All Rights Reserved.